@article{41821,
      note = {This resource was extracted from the Directory of Open  Access Journals (DOAJ)},
      author = {Heinrich, Michael and Scotti, Francesca and Andrade-Cetto,  Adolfo and Berger-Gonzalez, Monica and Echeverría, Javier  and Friso, Fabio and Garcia-Cardona, Felipe and Hesketh,  Alan and Hitziger, Martin and Maake, Caroline and Politi,  Matteo and Spadafora, Carmenza and Spadafora, Rita},
      url = {http://tind.wipo.int/record/41821},
      title = {Access and Benefit Sharing Under the Nagoya Protocol—Quo  Vadis? Six Latin American Case Studies Assessing  Opportunities and Risk},
      abstract = {Global challenges related to access and benefit sharing  (ABS) of biological resources have become a key concern in  the area of research on herbal medicines,  ethnopharmacology, drug discovery, and the development of  other high value products for which Intellectual Property  protection can be secured. While the Convention on  Biological Diversity (CBD, Rio 1992) has been recognized as  a huge step forward, the implementation of the Nagoya  Protocol (NP) and of new forms of collaboration often  remain unresolved, especially in the context of “the fair  and equitable sharing of benefits arising from the  utilization of genetic resources” (Convention on  Biological Diversity, 2011). The vision and the specific  implementation of this international treaty vary from  country to country, which poses additional challenges.  Using a case study approach, in this analysis we aim at  understanding the specific opportunities and challenges for  implementing international collaborations regarding ABS in  six Latin American countries—Chile, Colombia, Guatemala,  México, Panama, and Peru. Based on that analysis, we  provide recommendations for the path ahead regarding  international collaborations under ABS agreements in  ethnopharmacological research.},
      recid = {41821},
      pages = {19 pages},
}